Laura Tang

1.2k total citations
15 papers, 794 citations indexed

About

Laura Tang is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Laura Tang has authored 15 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Epidemiology and 7 papers in Neurology. Recurrent topics in Laura Tang's work include Neuroendocrine Tumor Research Advances (7 papers), Neuroblastoma Research and Treatments (7 papers) and Lung Cancer Research Studies (6 papers). Laura Tang is often cited by papers focused on Neuroendocrine Tumor Research Advances (7 papers), Neuroblastoma Research and Treatments (7 papers) and Lung Cancer Research Studies (6 papers). Laura Tang collaborates with scholars based in United States, Canada and China. Laura Tang's co-authors include Murray F. Brennan, Yuman Fong, Mithat Gönen, Vivian E. Strong, Jennifer A. Chan, Daniel G. Coit, Michael I. D’Angelica, Karim Touijer, Francesco Paolo Prete and Þorvarður R. Hálfdánarson and has published in prestigious journals such as Clinical Cancer Research, Journal of Antimicrobial Chemotherapy and Annals of Surgical Oncology.

In The Last Decade

Laura Tang

15 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Tang United States 11 526 495 360 156 95 15 794
Viktor Johanson Sweden 20 621 1.2× 542 1.1× 446 1.2× 165 1.1× 143 1.5× 43 1.0k
Venessa Tsang Australia 21 322 0.6× 600 1.2× 130 0.4× 214 1.4× 391 4.1× 48 1.1k
Marianna Macerelli Italy 12 136 0.3× 284 0.6× 206 0.6× 73 0.5× 73 0.8× 28 619
Mary Kate Kasler United States 6 135 0.3× 620 1.3× 56 0.2× 60 0.4× 49 0.5× 8 713
Shane Y. Morita United States 9 169 0.3× 231 0.5× 86 0.2× 151 1.0× 42 0.4× 22 503
Alberto Antonicelli United States 12 362 0.7× 119 0.2× 695 1.9× 193 1.2× 336 3.5× 17 898
Bonnie J. Trochanowski United States 4 331 0.6× 582 1.2× 209 0.6× 119 0.8× 10 0.1× 5 759
María Apellániz-Ruiz Spain 16 123 0.2× 277 0.6× 89 0.2× 138 0.9× 22 0.2× 36 667
Lajhem Cambridge United States 6 130 0.2× 516 1.0× 53 0.1× 125 0.8× 45 0.5× 8 603
Kae Kawachi Japan 14 105 0.2× 186 0.4× 60 0.2× 144 0.9× 45 0.5× 48 542

Countries citing papers authored by Laura Tang

Since Specialization
Citations

This map shows the geographic impact of Laura Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Tang more than expected).

Fields of papers citing papers by Laura Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Tang. The network helps show where Laura Tang may publish in the future.

Co-authorship network of co-authors of Laura Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Tang. A scholar is included among the top collaborators of Laura Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Tang. Laura Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Raj, Nitya, Youyun Zheng, Joanne F. Chou, et al.. (2021). Ribociclib and everolimus in well-differentiated foregut neuroendocrine tumors. Endocrine Related Cancer. 28(4). 237–246. 6 indexed citations
2.
Yaeger, Rona, Viktoriya Paroder, ‬David D. B. Bates, et al.. (2020). Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis. Clinical Colorectal Cancer. 19(4). e151–e156. 8 indexed citations
3.
Buege, Michael J., et al.. (2020). Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents. Annals of Pharmacotherapy. 54(9). 879–898. 4 indexed citations
4.
Hálfdánarson, Þorvarður R., Jonathan Strosberg, Laura Tang, et al.. (2020). The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors. Pancreas. 49(7). 863–881. 115 indexed citations
5.
Won, Elizabeth, Walid K. Chatila, Jaclyn F. Hechtman, et al.. (2019). Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer. Clinical Cancer Research. 25(13). 3811–3817. 14 indexed citations
6.
Tang, Laura, et al.. (2018). Current and Investigational Agents Targeting the Phosphoinositide 3‐Kinase Pathway. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 38(10). 1058–1067. 14 indexed citations
7.
Tang, Laura, Xiaohua Yang, Xiaoqiong Tang, et al.. (2018). Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study. Journal de Mycologie Médicale. 28(2). 379–383. 17 indexed citations
8.
Strosberg, Jonathan, Þorvarður R. Hálfdánarson, Andrew M. Bellizzi, et al.. (2017). The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors. Pancreas. 46(6). 707–714. 262 indexed citations
9.
Tang, Laura, Bernard L. Marini, Lydia L. Benitez, et al.. (2017). Risk factors for subtherapeutic levels of posaconazole tablet. Journal of Antimicrobial Chemotherapy. 72(10). 2902–2905. 38 indexed citations
10.
Knigge, Ulrich, Eva Tiensuu Janson, Lene Weber Vestermark, et al.. (2017). Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas. European Journal of Surgical Oncology. 43(9). 1682–1689. 40 indexed citations
11.
King, Amber C., et al.. (2017). Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid Malignancies. Annals of Pharmacotherapy. 51(5). 410–416. 32 indexed citations
12.
Yu, Run, et al.. (2016). A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series. Pancreas. 46(1). 48–56. 19 indexed citations
13.
Gaujoux, Sébastien, Mithat Gönen, Laura Tang, et al.. (2012). Synchronous Resection of Primary and Liver Metastases for Neuroendocrine Tumors. Annals of Surgical Oncology. 19(13). 4270–4277. 48 indexed citations
14.
Strong, Vivian E., Michael I. D’Angelica, Laura Tang, et al.. (2007). Laparoscopic Adrenalectomy for Isolated Adrenal Metastasis. Annals of Surgical Oncology. 14(12). 3392–3400. 176 indexed citations
15.
Roggin, Kevin K., Laura Tang, Elyn Riedel, et al.. (2007). P67. Journal of Surgical Research. 137(2). 264–264. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026